Literature DB >> 12927050

Polyamine metabolism and cancer.

Thresia Thomas1, T J Thomas.   

Abstract

Polyamines are aliphatic cations present in all cells. In normal cells, polyamine levels are intricately controlled by biosynthetic and catabolic enzymes. The biosynthetic enzymes are ornithine decarboxylase, S-adenosylmethionine decarboxylase, spermidine synthase, and spermine synthase. The catabolic enzymes include spermidine/spermine acetyltransferase, flavin containing polyamine oxidase, copper containing diamine oxidase, and possibly other amine oxidases. Multiple abnormalities in the control of polyamine metabolism and uptake might be responsible for increased levels of polyamines in cancer cells as compared to that of normal cells. This review is designed to look at the current research in polyamine biosynthesis, catabolism, and transport pathways, enumerate the functions of polyamines, and assess the potential for using polyamine metabolism or function as targets for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927050      PMCID: PMC6740079          DOI: 10.1111/j.1582-4934.2003.tb00210.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  88 in total

1.  Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma.

Authors:  Patricia A Thompson; Betsy C Wertheim; Jason A Zell; Wen-Pin Chen; Christine E McLaren; Bonnie J LaFleur; Frank L Meyskens; Eugene W Gerner
Journal:  Gastroenterology       Date:  2010-06-09       Impact factor: 22.682

2.  Phase I/II clinical trial of 2-difluoromethyl-ornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinoma.

Authors:  K A Skorupski; T G O'Brien; T Guerrero; C O Rodriguez; M R Burns
Journal:  Vet Comp Oncol       Date:  2011-03-08       Impact factor: 2.613

3.  Cell-autonomous circadian clock of hepatocytes drives rhythms in transcription and polyamine synthesis.

Authors:  Ann Atwood; Robert DeConde; Susanna S Wang; Todd C Mockler; Jamal S M Sabir; Trey Ideker; Steve A Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

4.  Probing tRNA interaction with biogenic polyamines.

Authors:  Amin Ahmed Ouameur; Philippe Bourassa; Heidar-Ali Tajmir-Riahi
Journal:  RNA       Date:  2010-08-20       Impact factor: 4.942

5.  Targeting polyamine biosynthetic pathway through RNAi causes the abrogation of MCF 7 breast cancer cell line.

Authors:  Enna Dogra Gupta; Manendra Pachauri; Prahlad Chandra Ghosh; Manchikatla Venkat Rajam
Journal:  Tumour Biol       Date:  2015-08-16

6.  Linear polyalkylamines as fingerprinting agents in capillary electrophoresis of low-molecular-weight heparins and glycosaminoglycans.

Authors:  J Timothy King; Umesh R Desai
Journal:  Electrophoresis       Date:  2011-10-17       Impact factor: 3.535

7.  Transport of polyamines in Drosophila S2 cells: kinetics, pharmacology and dependence on the plasma membrane proton gradient.

Authors:  Rafael Romero-Calderón; David E Krantz
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

8.  A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model.

Authors:  Hirak S Basu; Todd A Thompson; Dawn R Church; Cynthia C Clower; Farideh Mehraein-Ghomi; Corey A Amlong; Christopher T Martin; Patrick M Woster; Mary J Lindstrom; George Wilding
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

Review 9.  Metabolic interactions with cancer epigenetics.

Authors:  Xia Gao; Michael A Reid; Mei Kong; Jason W Locasale
Journal:  Mol Aspects Med       Date:  2016-09-09

10.  Treatment of prostate cancer cells with adenoviral vector-mediated antisense RNA using androgen-dependent and androgen-independent promoters.

Authors:  Wei Li
Journal:  Med Oncol       Date:  2009-06-11       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.